Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5441_Библиотеки_им_академика_М_И_Перельмана.pdf
239
Malvern Instruments, Worcestershire, UK). There is no direct method for the mea-
surement of zeta potential. Theoretical models or experimental calculation of zeta
potential is performed by measuring the electrophoretic mobility generated through
electroacoustic or electrokinetic phenomena. The electrokinetic effects are observed
due to electro-osmosis, electrophoresis, colloidal vibrations, and changes in sedi-
mentation potential (Kamble etal. 2022).
9.6.7 Determination ofElectrical Conductivity
When describing emulsions, electrical conductivity is vital because it gives details
about their composition, stability, and ow characteristics. The stability of emul-
sions can be altered over time by measuring electrical conductivity of an emulsion.
Enhanced surfactant concentrations and charge densities generally result in a higher
electrical conductivity in the emulsion (Chiesa etal. 2008). A conductivity metre or
probe (Mettler Toledo SevenCompact™ Conductivity Meters) can be used to mea-
sure electrical conductivity by inserting it into the emulsion sample and measuring
its capacity to conduct an electric current. Conductivity measurements are useful for
understanding the mechanism of emulsion separation, predicting the long-term sta-
bility, and examining the interactions between surfactants (Kasprzak etal. 2023).
Emulsions with higher electrical conductivity have been found to be more stable.
This is because a barrier against droplet aggregation and occulation is formed by
the electric double layers that form around the droplets. Coalescence is essentially
hindered by these multiple layers, which create repulsive forces between the drop-
lets. Moreover, conductive substances like carbon nanotubes can be added to emul-
sions to increase their stability and electrical conductivity (Briggs etal. 2018).
9.7 Conclusion
In this chapter emulsions are described in detail. The formation of O/W and W/O
emulsions is governed by adsorption, interfacial lm, and oriented wedge theories.
According to these proposed theories, interfacial interactions and wettability of the
emulsiers at the oil-water interfaces favour the formation of a stable emulsion.
This chapter has also focused on the major types of advanced emulsions currently
available, including macroemulsions, microemulsions, nanoemulsions, multiple
emulsions, and pickering emulsions. Emulsions are unstable systems and are often
difcult to prepare. Commercially feasible large-scale preparation techniques and
materials are still needed to develop a stable emulsion. Micro- and nanoemulsions
are superior to macroemulsions when it comes to delivering bioactive substances
and drugs. They have higher retention efciency, stability, better bioavailability, and
the capacity to regulate or trigger the release of drugs. One of the frontier topics in
structured fats and oils is double emulsions with a distinct structure, typically formed
through multiple-interface stabilization. It can trap signicant volumes of liquid oils
inside a single internal space. However, the biological fate of these emulsions is
9 Liquid andPolydisperse Systems: Emulsions
240
currently not well understood, and further study is needed in this eld. The phenom-
ena of instability, effects of interfacial lms on the long-term stability of emulsions,
and evaluation using various techniques have been summarized. Various instru-
ments used in the evaluation of emulsions have also been discussed in detail. In
general, the chapter has the potential to shape forthcoming developments in the
creation of innovative methods for producing sophisticated emulsions appropriate
for use in pharmaceutical applications.
Acknowledgements The authors thank their respective universities for providing support in con-
structing the manuscript.
Conicts of Interest The authors declare no conict of interest.
Funding: Not applicable.
Author Contributions: B.B. contributed to the conceptualization, investigation, methodology,
and writing and editing of the review; M.K.C. took part in the conceptualization, investigation,
methodology, and writing and editing of the review, as well as supervision.
References
Nour AH (2018) Emulsion types, stability mechanisms and rheology: a review. Int J Innov Res Sci
Stud 1(1):14–21
Alexandrov DV, Ivanov AA, Nizovtseva IG, Lippmann S, Alexandrova IV, Makoveeva EV (2022)
Evolution of a polydisperse ensemble of spherical particles in a metastable medium with allow-
ance for heat and mass exchange with the environment. Crystals 12(7):949
Aslam M, Deeb G, Ahmad MZ, Jain K, Ahmad J (2023) Functionalized nanoemulsions:
could be a promising approach for theranostic applications. In: Jain K, Jain NK (eds)
Multifunctional and targeted theranostic nanomedicines. Springer, Singapore. https://doi.
org/10.1007/978-981-99-0538-6_7
Briggs N, Raman AKY, Barrett L, Brown C, Li B, Leavitt D etal (2018) Stable Pickering emul-
sions using multi-walled carbon nanotubes of varying wettability. Colloids Surf Physicochem
Eng Asp 537:227–235
Chalapud MC, Baümler ER, Carelli AA (2018) Emulsions of sunower wax in pectin aqueous
solutions: physical characterization and stability. Food Res Int 108:216–225
Chen L, Ao F, Ge X, Shen W (2020a) Food-grade Pickering emulsions: preparation, stabilization
and applications. Molecules 25(14):3202
Chen H, Wang D, Wang X etal (2020b) Triple phase inversion of emulsions stabilized by amphi-
philic graphene oxide and cationic surfactants. ACS Omega 5(37):23524–23532. https://doi.
org/10.1021/acsomega.0c01398
Chiesa M, Garg J, Kang YT, Chen G (2008) Thermal conductivity and viscosity of water-in-oil
nanoemulsions. Colloids Surf Physicochem Eng Asp. 326(1):67–72
Cunha AG, Mougel J-B, Cathala B, Berglund LA, Capron I (2014) Preparation of double Pickering
emulsions stabilized by chemically tailored nanocelluloses. Langmuir 30(31):9327–9335.
https://doi.org/10.1021/la5017577
Dekker RI, Kibbelaar HV, Deblais A, Bonn D (2022) Rheology of emulsions with polymer solu-
tions as the continuous phase. J Non-Newton Fluid Mech 310:104938
Delahaije RJBM, Gruppen H, van Nieuwenhuijzen NH etal (2013) Effect of glycation on the oc-
culation behavior of protein-stabilized oil-in-water emulsions. Langmuir 29(49):15201–15208.
https://doi.org/10.1021/la403504f
K. Shubham et al.
241
Delahaije RJBM, Hilgers RJ, Wierenga PA, Gruppen H (2017) Relative contributions of charge
and surface coverage on pH-induced occulation of protein-stabilized emulsions. Colloids Surf
Physicochem Eng Asp 521:153–160
Dickinson E (2019) Strategies to control and inhibit the occulation of protein-stabilized oil-in-
water emulsions. Food Hydrocoll 96:209–223
Friberg SE, Quencer LG, Hilton ML (1996) Theory of emulsions. In: Pharmaceutical dosage
forms, 2nd edn. CRC Press
Fuhrmann PL, Breunig S, Sala G, Sagis L, Stieger M, Scholten E (2022) Rheological behaviour
of attractive emulsions differing in droplet-droplet interaction strength. J Colloid Interface Sci
607:389–400
Glatter O, Salentinig S (2020) Inverting structures: from micelles via emulsions to internally self-
assembled water and oil continuous nanocarriers. Curr Opin Colloid Interface Sci 49:82–93
Goodarzi F, Zendehboudi S (2019) A comprehensive review on emulsions and emulsion stability
in chemical and energy industries. Can J Chem Eng 97(1):281–309
Gowda D, Sarathchandraprakash NK, Mahendra C etal (2013) Emulsions and emulsiers—a
review. Asian J Exp Chem 8:30–45
Gurpreet K, Singh SK (2018) Review of nanoemulsion formulation and characterization tech-
niques. Indian J Pharm Sci 80(5):781
Hejazifar M, Lanaridi O, Bica-Schröder K (2020) Ionic liquid based microemulsions: a review. J
Mol Liq 303:112264
Ho TM, Razzaghi A, Ramachandran A et al (2024) Emulsion characterization via microuidic
devices: a review on interfacial tension and stability to coalescence. Adv Colloid Interf Sci
299:102541
Hong IK, Kim SI, Lee SB (2018) Effects of HLB value on oil-in-water emulsions: droplet size,
rheological behavior, zeta-potential, and creaming index. J Ind Eng Chem 67:123–131
Hosseini A, Jafari SM, Mirzaei H, Asghari A, Akhavan S (2015) Application of image process-
ing to assess emulsion stability and emulsication properties of Arabic gum. Carbohydr
Polym 126:1–8
Hu YT, Ting Y, Hu JY, Hsieh SC (2017) Techniques and methods to study functional characteris-
tics of emulsion systems. J Food Drug Anal 25(1):16–26
Huck-Iriart C, Montes-de-Oca-Ávalos J, Herrera ML, Candal RJ, Pinto-de-Oliveira CL, Linares-
Torriani I (2016) New insights about occulation process in sodium caseinate-stabilized emul-
sions. Food Res Int 89:338–346
Jena AK, Nayak AK, De A, Mitra D, Samanta A (2018) Development of lamivudine containing
multiple emulsions stabilized by gum odina. Future J Pharm Sci 4(1):71–79
Jintapattanakit A (2018) Preparation of nanoemulsions by phase inversion temperature (PIT)
method. Pharm Sci Asia 45(1):1–12
Juneja M, Suthar T, Pardhi VP, Ahmad J, Jain K (2022) Emerging trends and promises of nano-
emulsions in therapeutics of infectious diseases. Nanomedicine (Lond) 17(11):793–812.
https://doi.org/10.2217/nnm-2022-0006. Epub 2022 May 19. PMID: 35587031
Kale SN, Deore SL (2017) Emulsion micro emulsion and nano emulsion: a review. Syst Rev
Pharm 8:39
Kamble S, Agrawal S, Cherumukkil S, Sharma V, Jasra RV, Munshi P (2022) Revisiting zeta
potential, the key feature of interfacial phenomena, with applications and recent advancements.
ChemistrySelect 7(1):e202103084
Kasprzak MM, Berski W, Krystyjan M etal (2023) Effects of bre addition and processing on the
stability, rheology and invitro gastric digestion of whey protein-xanthan gum stabilised emul-
sions with high oil phase. LWT 178:114465
Khedr A, Striolo A (2019) Quantication of ostwald ripening in emulsions via coarse-grained sim-
ulations. J Chem Theory Comput 15(9):5058–5068. https://doi.org/10.1021/acs.jctc.9b00296
Kim H, Park D, Jiang Z, Wei Y, Woong KJ (2022) Microuidic macroemulsion stabilization
through in situ interfacial coacervation of associative nanoplatelets and polyelectrolytes. J
Colloid Interface Sci 614:574–582
9 Liquid andPolydisperse Systems: Emulsions
242
Koroleva MY, Yurtov EV (2021) Ostwald ripening in macro- and nanoemulsions. Russ Chem Rev
90:293. https://doi.org/10.1070/RCR4962
Kumar A, Li S, Cheng C-M, Lee D (2015) Recent developments in phase inversion emulsication.
Ind Eng Chem Res 54(34):8375–8396. https://doi.org/10.1021/acs.iecr.5b01122
Kumar D, Yadav S, Ujjwal RR, Jain K (2021) “Chapter 6: Interfacial characterization of nano-
emulsion” in International Book “Nanoemulsions in food technology: development, character-
ization and applications” CRC Press, USA. ISBN: 9780367614928
Kupikowska-Stobba B, Domagała J, Kasprzak MM (2024) Critical review of techniques for food
emulsion characterization. Appl Sci 14(3):1069. https://doi.org/10.3390/app14031069
Langevin D (2019) Coalescence in foams and emulsions: similarities and differences. Curr Opin
Colloid Interface Sci 44:23–31
Lipei F, Ma Q, Liao K, An J, Bai J, He Y (2021) Application of Pickering emulsion in oil drilling
and production. Nanotechnol Rev 11(1). https://doi.org/10.1515/ntrev- 2022- 0003/html
Liu H, Shi J, Pu Y, Wang JX, Wang D, Chen JF (2020) In situ visualization and real-time track-
ing of emulsion and miniemulsion polymerization at the microscale via uorescence imaging.
Chem Eng Sci 211:115288
Llamas S, Santini E, Liggieri L, Salerni F, Orsi D, Cristofolini L etal (2018) Adsorption of sodium
dodecyl sulfate at water–dodecane interface in relation to the oil in water emulsion properties.
Langmuir 34(21):5978–5989
Lu T, Yu F, Xue C, Han B (2021) Identication, classication, and quantication of three physi-
cal mechanisms in oil-in-water emulsions using AlexNet with transfer learning. J Food Eng
288:110220
McClements DJ, Jafari SM (2018) Improving emulsion formation, stability and performance using
mixed emulsiers: a review. Adv Colloid Interf Sci 251:55–79
Mirhosseini H, Tan CP (2010) Discrimination of orange beverage emulsions with different formu-
lations using multivariate analysis. J Sci Food Agric 90(8):1308–1316. https://doi.org/10.1002/
jsfa.3928
Moghaddam MK, Moezzi M, Dannandeh F (2023) Oil–water separation in kitchen waste-
water ltration using milkweed oss ber. Biomass Conv Bioref. https://doi.org/10.1007/
s13399- 023- 05190- w
Narayan S, Metaxas AE, Bachnak R, Neumiller T, Dutcher CS (2020) Zooming in on the role
of surfactants in droplet coalescence at the macroscale and microscale. Curr Opin Colloid
Interface Sci 50:101385
Nikmaram N, Roohinejad S, Hashemi S, Koubaa M etal (2017) Emulsion-based systems for
fabrication of electrospun nanobers: food, pharmaceutical and biomedical applications. RSC
Adv 7(46):28951–28964
Pal N, Kumar S, Bera A, Mandal A (2019) Phase behaviour and characterization of microemul-
sion stabilized by a novel synthesized surfactant: implications for enhanced oil recovery. Fuel
235:995–1009
Pardhi VP, Suthar T, Sharma A, Jain K (2022) Bedaquiline fumarate microemulsion: formula-
tion optimization, rheological characterization and in vitro studies. Nanomedicine (Lond)
17(21):1529–1546. https://doi.org/10.2217/nnm-2022-0132. Epub 2022 Nov 23. PMID:
36416115
Park SH, Hong CR, Choi SJ (2020) Prevention of Ostwald ripening in orange oil emulsions:
impact of surfactant type and Ostwald ripening inhibitor type. LWT 134:110180
Pinto I, Buss A (2020) ζ potential as a measure of asphalt emulsion stability. Energy Fuel
34(2):2143–2151
Prankerd RJ, Stella VJ (1990) The use of oil-in-water emulsions as a vehicle for parenteral drug
administration. PDA J Pharm Sci Technol 44(3):139–149
Pratishtha, Gupta MK, Gupta S (2021) Multiple emulsions: emphasizing on industrial applications.
In: Patel JK, Pathak YV (eds) Emerging technologies for nanoparticle manufacturing. Springer
International Publishing, Cham, pp333–347. https://doi.org/10.1007/978- 3- 030- 50703- 9_14
Rahn-Chique K, Puertas AM, Romero-Cano MS, Rojas C, Urbina-Villalba G (2012) Nanoemulsion
stability: experimental evaluation of the occulation rate from turbidity measurements. Adv
Colloid Interf Sci 178:1–20
K. Shubham et al.
243
Ravera F, Dziza K, Santini E, Cristofolini L, Liggieri L (2021) Emulsication and emulsion stabil-
ity: the role of the interfacial properties. Adv Colloid Interf Sci 288:102344
Ravindran S, Williams MAK, Ward RL, Gillies G (2018) Understanding how the properties of
whey protein stabilized emulsions depend on pH, ionic strength and calcium concentration, by
mapping environmental conditions to zeta potential. Food Hydrocoll 79:572–578
Roberts C (2002) A new theory of emulsions. J Phys Chem 36(12):3087–3107
Santos ICVM, Oliveira PF, Mansur CRE (2017) FACTORS THAT AFFECT CRUDE OIL
VISCOSITY AND TECHNIQUES TO REDUCE IT: A REVIEW.Braz J Pet Gas 11(2):115.
https://doi.org/10.5419/bjpg2017- 0010
Saygı-Arslan Ö, Sudol ED, Daniels ES, El-Aasser MS, Klein A (2009) In situ surfactant genera-
tion as a means of miniemulsication? J Appl Polym Sci 111(2):735–745
Shinoda R, Uchimura T (2018) Evaluating the creaming of an emulsion via mass spectrometry
and UV–Vis spectrophotometry. ACS Omega 3(10):13752–13756. https://doi.org/10.1021/
acsomega.8b02283
Shiraki K, Mimura M, Nishinami S, Ura T (2020) Effect of additives on liquid droplets and aggre-
gates of proteins. Biophys Rev 12(2):587–592
Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A (2018) Biomedical applications of
microemulsion through dermal and transdermal route. Biomed Pharmacother 108:1477–1494
Silva CAM, Saraiva SV, Bonetti D, Higuti RT, Cunha RL, Pereira LOV etal (2022) Measurements
of bimodal droplet size distribution of emulsions using ultrasonic spectroscopy in the long and
intermediate wavelength regimes. Chem Eng Sci 252:117274
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK etal (2017) Nanoemulsion: con-
cepts, development and applications in drug delivery. J Control Release 252:28–49
Suthar T, Jain VK, Popli H, Jain K (2022) “Chapter 12: Nanoemulsions as effective carriers for
targeting brain tumors” in International Book “Nanocarriers for drug-targeting to brain tumors”
Elsevier 1–17. ISBN: 9780323907736; https://doi.org/10.1016/B978-0-323-90773-6.00008-7
Suthar T, Patel P, Singh P, Datusalia AK, Yadav AK, Jain K et al (2023) Hesperidin microemul-
sion: formulation optimization, characterization, and in vitro evaluation. J Drug Deliv Technol
80(104166):1–12. https://doi.org/10.1016/j.jddst.2023.104166
Tao C, Kutchko BG, Rosenbaum E, Massoudi M (2020) A review of rheological modeling of
cement slurry in oil well applications. Energies 13(3):570
Tian Y, Yuan C, Cui B, Lu L, Zhao M, Liu P et al (2022) Pickering emulsions stabilized by
β-cyclodextrin and cinnamaldehyde essential oil/β-cyclodextrin composite: a comparison
study. Food Chem 377:131995
Umar AA, Saaid IBM, Sulaimon AA, Pilus RBM (2018) A review of petroleum emulsions and
recent progress on water-in-crude oil emulsions stabilized by natural surfactants and solids. J
Pet Sci Eng 165:673–690
Vv H, Vishal P, Borawake D, Hs N (2018) Nanoemulsion: a novel platform for drug delivery sys-
tem. J Mater Sci Nanotechnol 6:1–11
Wang XY, Wang J, Rousseau D, Tang CH (2020) Chitosan-stabilized emulsion gels via pH-
induced droplet occulation. Food Hydrocoll 105:105811
Wang M, Zhang J, Fan L, Li J (2023) Fabrication of fat-reduced water-in-oil emulsion and the
application in 3D printing. Food Res Int 172:113118
Yang Y, Fang Z, Chen X, Zhang W, Xie Y, Chen Y etal (2017) An overview of Pickering emul-
sions: solid-particle materials, classication, morphology, and applications. Front Pharmacol
8:287. https://doi.org/10.3389/fphar.2017.00287
Zhang X, Xing H, Zhao Y, Ma Z (2018) Pharmaceutical dispersion techniques for dissolution and
bioavailability enhancement of poorly water-soluble drugs. Pharmaceutics 10(3):74. https://
doi.org/10.3390/pharmaceutics10030074
Zhang Y, Xie Y, Liu H, McClements DJ, Cheng C, Zou L etal (2022) Probiotic encapsulation in
water-in-oil high internal phase emulsions: enhancement of viability under food and gastroin-
testinal conditions. LWT 163:113499
Zwicker D, Hyman AA, Jülicher F (2015) Suppression of Ostwald ripening in active emulsions.
Phys Rev E 92:012317. https://doi.org/10.1103/PhysRevE.92.012317
9 Liquid andPolydisperse Systems: Emulsions
245
10
Sterile Products andAdmixtures
SatishShilpi, AmitK.Dubey, ShaliniBajaj,
ShashankShekarMishra, ChetanRam, DebasisGantayat,
VibhootiPippola, andKhyatiSaini
Abstract
The aseptically prepared large volume parenteral containing important necessary
nutritional components for benecial effect such as vitamins, glucose, amino
acids, fats, etc. with pharmaceutical active drug is called parenteral admixture. It
is manufactured directly by pharmaceutical companies after exhaust analysis of
potential chemical or pharmaceutical interactions within the admixture and
drugs. Before that nurses and physicians manufacture the admixtures in the hos-
pital for the particular patient during their hospitalization using individually
packed sterile components to maintain aseptic condition. The purpose of paren-
teral admixture is to enhance the therapeutic effectiveness as well as the stability
of the product, reduce the side effect of the drug, and maintain the nutritional and
electrolyte balance in the body. Parenteral admixture-utilizing countries regulate
the manufacturing practice to assure the quality, stability, and microbiological
integrity of the parenteral admixture. In the chapter, brief discussion of additives,
their application, manufacturing, and regulatory aspects has been explored.
Keywords
Admixtures · Parenterals · Therapeutic benets · Sterile · Nutritional value
S. Shilpi (*) · A. K. Dubey · S. S. Mishra · C. Ram · D. Gantayat · V. Pippola · K. Saini
School of Pharmaceuticals and Population Health Informatics, Faculty of Pharmacy, DIT
University, Dehradun, India
S. Bajaj
School of Pharmaceuticals Sciences, Jaipur National University, Jaipur, Rajasthan, India
246
10.1 Introduction
10.1.1 Additives inParenteral Products
Parenteral admixtures refer to mixtures of medications or solutions that are pre-
pared for administration through routes other than the digestive tract, typically by
injection. This can include intravenous (IV), intramuscular (IM), subcutaneous
(SC), or other routes. These admixtures are carefully prepared to ensure the proper
dosing, compatibility of ingredients, sterility, and safety for the patient. Drug deliv-
ery methods designed for injection or infusion, known as parenteral formulations,
have advanced signicantly in the last several years (Ezike etal. 2023). When preci-
sion doses, fast onset, and high bioavailability are needed, parenteral formulations
are essential for delivering drugs. Parenteral products are a class of pharmaceuticals
designed to be administered directly into the body, bypassing the digestive system
(Manchanda etal. 2020; Nikam Nikita etal. 2023). These products, including injec-
tions, infusions, and implants, are formulated to deliver medications, vaccines, or
nutrients directly into the bloodstream, tissues, or organs (Nema etal. 2007). By
circumventing the digestive process, parenteral products can provide rapid and tar-
geted relief, making them ideal for treating emergencies, chronic conditions, and
diseases that require immediate intervention. The drug then moves from the place of
administration to the site of action. To deliver drugs that are ineffective when taken
orally, that are destroyed in the gastrointestinal tract, or that are utilized to treat
patients who are uncooperative, nauseous, or unconscious, parenteral administra-
tion provides an instant physiological reaction (Kapp 2018). Parenteral administra-
tion can have localized effects, offer a longer-lasting pharmacological effect, and
ultimately restore signicant imbalances in uid and electrolyte levels (Ezike etal.
2023). However, parenteral dose forms involve aseptic procedures, require more
time than other routes, must be administered by trained personnel, and typically
cause pain at the injection site.
Parenteral products are an essential part of contemporary healthcare since they
can also provide better bioavailability, fewer side effects, and increased patient
compliance. Pharmaceutical excipients, often known as additives, are substances
that are added to completed pharmaceutical products to fulll specic purposes
(Pramanick et al. 2013). In the large volume parenterals, some substances with
nutritional value or other benecial effect are added which is called parenteral
admixtures. The substances may be vitamins, glucose, amino acids, and fats which
are added as an admixture in the parenteral formulation. They are included to
increase bulk, facilitate production, enhance stability, improve drug targeting and
administration, and alter the pharmacokinetic or safety prole of the drug (Nema
etal. 2007; Rayaprolu etal. 2018). To distinguish them from active pharmaceutical
compounds, excipients are generally referred to as inactive or inert ingredients.
Some countries have imposed limitations on the kind or quantity of excipient that
can be used in the formulation of parenteral medicinal products because of safety
concerns (Pramanick et al. 2013). For instance, even though these additives are
present in products in other countries, the use of amino mercuric chloride or
S. Shilpi et al.
247
thimerosal is restricted in Japan, the United States, and the European Union (Nema
and Brendel 2016).
The aim of the addition of additives to parenteral products is:
• To enhance or uphold the stability of the product
• To increase or maintain the solubility of active ingredients
• To ensure safety and sterility
• To reduce pain and irritation during the injection
• To control or extend the release of drugs
• To stabilize the therapeutic molecules
• To synergize the therapeutic effects of drugs
The composition of any parenteral dosage form includes drugs, additives, vehi-
cles, and containers (Ahmed etal. 2018). The ingredient in the product that gives it
its pharmacological effect is the active drug. Parenteral products are designed to be
reconstituted as solutions. These formulations include liposomes, suspensions,
emulsions, powders, and nanosystems. These are frequently utilized in freeze-dried
products and parenteral formulations that concentrate a solution. Developing a reli-
able and safe parenteral dosage form requires extensive investigation of the active
drug’s or drugs’ physical and chemical characteristics. Parenteral additives are com-
pounds that are added to parenteral solutions to stabilize parenteral products, con-
trol their properties, maintain sterility, or facilitate delivery by lessening tissue
irritation or injection discomfort (Ludwig 2019). To prevent interfering with the
therapeutic efcacy of the drugs and assays or tests, as well as to ensure that the
concentrations of these additives are safe and nontoxic, they should be used in the
smallest number and quantities possible, especially in LVP (large volume paren-
teral) (Dongare etal. 2015). Furthermore, various additives used in parenteral prod-
ucts are summarized here under the scope of additives in parenteral products.
Parenteral products have a wide range of additives that are specically intended for
specic formulation criteria. This ensures the safety, efcacy, stability, and patient
acceptance of these vital treatments. Throughout every phase of their administration
and shelf life, each additive is essential to maintaining the effectiveness and quality
of parenteral formulations (Table10.1).
Table 10.1 Role of admixture in parenterals
Benet Description
Nutritional support Provides essential nutrients to patients unable to consume sufcient
nutrients orally
Remediation of
deciencies
Addresses specic deciencies in vitamins, minerals, and other
nutrients
Therapeutic benets Antioxidants reduce oxidative stress; amino acids aid in tissue repair
and immune function
Stabilization of
solutions
Electrolytes maintain osmolarity and pH balance, ensuring solution
stability
10 Sterile Products andAdmixtures
248
10.1.2 Admixture inParenteral: AStability Monitor
Regardless of the nation, intravenous admixture compounding is standard proce-
dure in the most hospitals worldwide. Working in an aseptic setting presents chal-
lenges for the compounder, and compounding intravenous drugs carries a risk due
to the signicant potential for error resulting from their complexity (Allen 2021).
The effects of six distinct independent parameters on the stability of intravenous
feeding were examined. Prentral admixtures were prepared with the following com-
ponents so they could be given intravenously: amino acids, should be 2–7%;
hydrated glucose, up to 20%; lipid emulsion, 5%; monovalent cations, starting from
0 to 150meq/L; divalent cations, in the range of 4–20meq/L; and the last, but not
least, trivalent cations, ranging from 0 to 10mg of elemental iron/L.Stability assess-
ments included eye inspection, pH monitoring, and particle-size analysis (Driscoll
etal. 1995; Boullata etal. 2022).
Parenteral nutrition (PN) is a high-alert medication that can be utilized to treat
patients during a challenging clinical procedure. Once the specic clinical guidelines
were produced by consensus, the Board of Directors of the American Society for
Parenteral and Enteral Nutrition (ASPEN) evaluated and approved them. The follow-
ing questions were addressed: Does better PN ordering result from education for pre-
scribers? When administering PN admixtures via the peripheral vein, what is the
maximum safe osmolarity? What are the appropriate calcium intake and calcium-
phosphate ratios in PN for optimal infant bone mineralization? What are the therapeu-
tic advantages and disadvantages of using commercially available prefabricated
(“premixed”) multichambered PN formulations over traditional or customized PN
formulations (Otero-Millán etal. 2024a, b; Bakrey etal. 2024)? Other questions to
think about are the following: Which recommendations work best to maximize the
compatibility of phosphate (Na
+
or K
+
) and calcium (gluconate) in PN admixtures?
What kind of parenteral stock solutions that are used to make PN admixtures now
have micronutrient contamination? Is it okay to administer non-nutrient drugs using
the PN admixture as a delivery system? Is heparin added to the PN admixture required
to reduce the incidence of Cerebral venous thrombosis (CVT)? Which methods of
repackaging intravenous fat emulsion (IVFE) into customized, smaller volumes are
safe? Which expiration date is applicable to IVFE that has been repackaged and (a) is
administered in its original container for a separate infusion (Boullata etal. 2014)?
10.1.3 Rates andIntensity ofSeverity ofIntravenous Admixture
inHealthcare
When it comes to the installation of laryngeal mask airway (LMA), a drug propofol
(an anesthetic and a sedative) was contrasted with a solution of sodium pentothal
thiopental. A randomization process was used to assign patients, ages 18–65, to
receive 7.5mg of oral midazolam as a premedication. After then, they received
either 1% propofol or a 0.5% or 1.2% admixture. The doses given were at a rate of
0.25 mL/kg of body weight. The frequency and severity of gagging (the body’s
S. Shilpi et al.
249
natural response to keep someone from choking or eating anything disagreeable),
coughing, and insufcient jaw relaxation were satisfactory, and no signicant dif-
ference was found between pre- and post-therapy. Laryngospasm, a transient spasm
of the vocal cords that impairs speech or breathing, was one of the other conditions
that did not exhibit signicant differences (Yeo etal. 2001). In another case related
to admixtures in parenterals, according to recent statistics, total nutritional admix-
tures (TNAs) might be deemed pharmaceutically inappropriate for human adminis-
tration. It was estimated that the percentage of fat (PFAT) globules with a diameter
greater than 5μm accounts for more than 0.4% of the total fat content. TNAs are
unstable in this situation (Driscoll etal. 2000).
There were few proofs that the intravenous admixture preparation method and
location affect the number of errors that occur. Specically, it seems that intrave-
nous preparation in central pharmacy settings compared to nursing wards seems to
pose fewer risks. Indeed, automated versus manual preparation results in lower
error rates. An observational study was done by Dehmel and colleagues in which
errors rate was observed in the parentral admixture preparation. In case of auto-
mated preparation which was prepare at central phamacy, the erors rate was 16%
while 53% errors rate was observed in manual preparation which was prepaed in
nursing unit. They found a noticeably higher proportion of incorrect concentration
mistakes (53% vs. 16%, respectively) (Dehmel etal. 2011). In another study, Khalili
and colleagues found no cases of contamination in admixtures made in central phar-
macies. They found a low rate of bacterial contamination (1.1%) in admixtures
manufactured on nursing wards, despite the use of manual preparation processes in
each setting (Khalili etal. 2013).
Intravenous admixture preparation errors (IAPEs) might cause harm to the suf-
ferer. To inspire preventive actions, further research is required to determine the
prevalence and contributing factors of various IAPEs. Any mistake made during the
IV admixture preparation process, such as a departure from the medication order,
the local electronic admixture preparation instructions, or the manufacturer’s drug
information page, was classied as an IAPE.A study conducted by Jessurun and
co-workers led to the conclusion that IAPE occurs rarely. The factors associated
with IAPEs illustrate the components linked to working conditions and preparation
difculties. The solutions aimed at reducing the incidence of IAPEs and, in turn,
patient harm should center on the identied causes (Jessurun etal. 2022).
The information that is now available points to the necessity for standardization,
preventive strategic formulation, and implementation. The other factors to be con-
sidered may be staff training on ideal admixture protocols and ongoing optimization
of the intravenous preparation process. Future studies should concentrate on creat-
ing uniform denitions for error subtypes and standardizing reporting procedures.
Repeatable techniques and surveillance are needed to monitor risk factors and con-
nect them to the damage these errors cause (Hedlund etal. 2017).
This research aimed to establish a reliable and efcient method for measuring
ampicillin concentrations in total parenteral nutrition (TPN) admixtures using
reverse-phase high-performance liquid chromatography with diode-array detection
(RP-HPLC-DAD). They developed and validated an RP-HPLC-DAD method,
10 Sterile Products andAdmixtures